SYRS
Acadian Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-329,793
| Closed | -$9K | – | 1878 |
|
|
2025
Q1 | $9K | Buy |
329,793
+80,367
| +32% | +$2.19K | ﹤0.01% | 1562 |
|
|
2024
Q4 | $55K | Buy |
249,426
+196,560
| +372% | +$43.3K | ﹤0.01% | 1441 |
|
|
2024
Q3 | $113K | Buy |
52,866
+18,288
| +53% | +$39.1K | ﹤0.01% | 1550 |
|
|
2024
Q2 | $178K | Buy |
34,578
+17,416
| +101% | +$89.7K | ﹤0.01% | 1449 |
|
|
2024
Q1 | $91K | Buy |
+17,162
| New | +$91K | ﹤0.01% | 1305 |
|
|
2023
Q2 | – | Sell |
-12,776
| Closed | -$34K | – | 1946 |
|
|
2023
Q1 | $34K | Sell |
12,776
-4,966
| -28% | -$13.2K | ﹤0.01% | 1578 |
|
|
2022
Q4 | $62K | Sell |
17,742
-6,823
| -28% | -$23.8K | ﹤0.01% | 1538 |
|
|
2022
Q3 | $156K | Sell |
24,565
-112,374
| -82% | -$714K | ﹤0.01% | 1268 |
|
|
2022
Q2 | $132K | Buy |
136,939
+54,585
| +66% | +$52.6K | ﹤0.01% | 1297 |
|
|
2022
Q1 | $97K | Buy |
+82,354
| New | +$97K | ﹤0.01% | 1368 |
|
|
2021
Q3 | – | Sell |
-354,453
| Closed | -$1.93M | – | 2069 |
|
|
2021
Q2 | $1.93M | Buy |
+354,453
| New | +$1.93M | 0.01% | 717 |
|
|
2021
Q1 | – | Sell |
-11,652
| Closed | -$126K | – | 2364 |
|
|
2020
Q4 | $126K | Buy |
11,652
+6,966
| +149% | +$75.3K | ﹤0.01% | 1684 |
|
|
2020
Q3 | $41K | Sell |
4,686
-51,340
| -92% | -$449K | ﹤0.01% | 1908 |
|
|
2020
Q2 | $598K | Buy |
+56,026
| New | +$598K | ﹤0.01% | 1137 |
|
|
2020
Q1 | – | Sell |
-26,405
| Closed | -$182K | – | 1963 |
|
|
2019
Q4 | $182K | Buy |
+26,405
| New | +$182K | ﹤0.01% | 1317 |
|
|
2019
Q2 | – | Sell |
-10,788
| Closed | -$99K | – | 2077 |
|
|
2019
Q1 | $99K | Buy |
+10,788
| New | +$99K | ﹤0.01% | 1526 |
|
|
2018
Q4 | – | Sell |
-5,531
| Closed | -$66K | – | 1857 |
|
|
2018
Q3 | $66K | Sell |
5,531
-22,702
| -80% | -$271K | ﹤0.01% | 1300 |
|
|
2018
Q2 | $288K | Buy |
28,233
+27,840
| +7,084% | +$284K | ﹤0.01% | 998 |
|
|
2018
Q1 | $5K | Buy |
+393
| New | +$5K | ﹤0.01% | 1620 |
|